No profile data available.
Belite Bio, Inc (BLTE) is a healthcare company in the eye treatment pharmaceuticals industry, based in San Diego, United States, with about 41 full-time employees.
In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $6.22 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.
$6.22 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (eye treatment pharmaceuticals) include Regeneron Pharmaceuticals, Inc. (REGN), Kodiak Sciences Inc. (KOD), Bausch + Lomb Corporation (BLCO), MeiraGTx Holdings plc (MGTX).